Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

Role Of The Vitamin D‐endocrine System In The Pathophysiology Of Postmenopausal Osteoporosis

B. Riggs
Published 2003 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Impaired calcium absorption and impaired adaptation to a low calcium diet are common features of aging in women and these processes are even more severely impaired in patients with osteoporotic fractures. The calcium absorption defects are associated with several abnormalities of the vitamin D‐endocrine system including secondary hyperparathyroidism, intestinal resistance to 1,25‐dihydroxyvitamin D (1,25(OH)2D) action, decreased 1,25(OH)2D production due to impaired 25(OH)D 1α‐hydroxylase activity, and, in some elderly persons, nutritional deficiency of vitamin D. However, in postmenopausal women, most of these abnormalities are normalized by administration of physiologic replacement dosages of estrogen and, thus, appear to be secondary consequences of estrogen deficiency. Nonetheless, a minority of them, especially nutritional vitamin D deficiency and impaired 25(OH)D 1α‐hydroxylase activity late in life, appear to be primary and are independent of estrogen deficiency. J. Cell. Biochem. 88: 209–215, 2003. © 2002 Wiley‐Liss, Inc.
This paper references
Effect of alphacalcidol (1OHD3) on osteoporosis: multicenter double-blind study
Y Itami (1982)
10.1172/JCI110372
Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients.
D. Slovik (1981)
Tolerance to dose of calcitriol is associated with improved bone density in women with postmenopausal osteoporosis
S Pattanaungkul (1990)
10.1016/8756-3282(86)90001-3
The influence of age on bone mineral regulating hormones.
S. Epstein (1986)
10.1210/JCEM.75.1.1320048
Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women.
P. Ebeling (1992)
Vitamin D supplementation and fracture incidence in elderly persons . A randomized , placebo - controlled clinical trial
WR McKane (1996)
10.1007/BF00298438
Vitamin D receptor gene polymorphism, bone mass, body size, and vitamin D receptor density
M. Barger-Lux (2004)
Tolerance to dose of calcitriol
SM 110267–274.Ott (1990)
10.7326/0003-4819-124-4-199602150-00003
Vitamin D Supplementation and Fracture Incidence in Elderly Persons
P. Lips (1996)
turnover and modulates calcium - regulating hormones in early postmenopausal women
R Eastell (1997)
10.1097/00006254-199707000-00021
Role of estrogen deficiency in pathogenesis of secondary hyperparathyroidism and increased bone resorption in elderly women.
W. McKane (1997)
The unitary model
M. R. Olsen (1978)
10.1097/00006254-199305000-00026
Vitamin D3 and Calcium to Prevent Hip Fractures in Elderly Women
M. Chapuy (1993)
10.1097/00003086-199403000-00033
Alfacalcidol (alpha D3) and calcium in osteoporosis.
J. Menczel (1994)
10.1172/JCI107461
Effect of dietary calcium and age on jejunal calcium absorption in humans studied by intestinal perfusion.
P. Ireland (1973)
10.1359/jbmr.1997.12.6.922
Association Between Intestinal Vitamin D Receptor, Calcium Absorption, and Serum 1,25 Dihydroxyvitamin D in Normal Young and Elderly Women
H. K. Kinyamu (1997)
10.1002/JBMR.5650060205
Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: Evidence of an age‐related intestinal resistance to 1,25‐dihydroxyvitamin D action
R. Eastell (1991)
Osteomalacia as a risk factor for hip fractures in the USA
CC Johnston (1987)
10.7326/0003-4819-110-4-267
Calcitriol treatment is not effective in postmenopausal osteoporosis.
S. Ott (1989)
1 - Alpha - hydroxyvitamin D - 3 treatment decreases
JT Chen (1997)
10.1210/JCEM.86.8.7703
Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
J. Gallagher (2001)
10.1002/JBMR.5650100806
Vitamin D status and sex hormone binding globulin: Determinants of bone turnover and bone mineral density in elderly women
M. Ooms (1995)
10.1016/0378-5122(88)90029-1
Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1 alpha (OH)-vitamin D3.
H. Orimo (1987)
10.1007/BF00305521
Effects of 1α-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis
H. Orimo (2004)
10.1056/NEJM199202063260601
Treatment of postmenopausal osteoporosis with calcitriol or calcium.
M. Tilyard (1992)
10.1002/JBMR.5650111005
Effect of parathyroid hormone (hPTH[1‐34]) infusion on serum 1,25‐dihydroxyvitamin D and parathyroid hormone in normal women
H. K. Kinyamu (1996)
10.1056/NEJM199212033272305
Vitamin D3 and Calcium to Prevent Hip Fractures in Elderly Women
M. Chapuy (1992)
Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function and age in women: Evidence of an age-related intestinal resistance to 1,25(OH)2D action
R Eastell (1991)
[Vitamin D and its metabolites].
S. Masuda (1995)
10.1210/JCEM-61-3-457
Effect of long term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis.
B. Riggs (1985)
10.1172/JCI111373
Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis.
K. S. Tsai (1984)
10.1016/0002-9343(88)90259-8
Calcitriol in the treatment of postmenopausal osteoporosis.
J. Aloia (1988)
1-Alphahydroxyvitamin D-3 treatment decreases bone turnover and modulates calcium-regulating hormones in early postmenopausal women
JT Chen (1997)
Relationship of intest
WM O’Fallon (2000)
10.1210/ENDO.132.1.8419141
The presence of functional estrogen receptors in intestinal epithelial cells.
M. Thomas (1993)
10.1210/JCEM-71-5-1288
Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women.
C. Gennari (1990)
10.1172/JCI109516
Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.
J. Gallagher (1979)
[Vitamin D and osteoporosis].
S. Ljunghall (1995)
10.1210/JCEM.79.1.8027229
Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3.
G. Ledger (1994)
Calcitriol treatment is not
SM Ott (1989)
10.1016/S8756-3282(97)00054-9
1-α-Hydroxyvitamin D3 treatment decreases bone turnover and modulates calcium-regulating hormones in early postmenopausal women
J. Chen (1997)
10.1210/JCEM.80.12.8530583
Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause--a clinical research center study.
W. McKane (1995)
10.3181/00379727-191-42922
The Effect of Calcitriol on Patients with Postmenopausal Osteoporosis with Special Reference to Fracture Frequency
J. Gallagher (1989)
10.1210/JCEM.83.7.4924
Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen.
S. Khosla (1998)
Effects of 1 alpha - hydroxyvitamin D 3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis
SM Ott (1994)
10.1359/jbmr.1998.13.5.763
A Unitary Model for Involutional Osteoporosis: Estrogen Deficiency Causes Both Type I and Type II Osteoporosis in Postmenopausal Women and Contributes to Bone Loss in Aging Men
B. Riggs (1998)
10.1210/ENDO-126-2-1053
Advancing age results in reduction of intestinal and bone 1,25-dihydroxyvitamin D receptor.
R. Horst (1990)
10.1210/EDRV.22.4.0437
Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications.
P. Lips (2001)
10.1016/B978-012470862-4/50041-6
The Role of Parathyroid Hormone and Vitamin D in the Pathogenesis of Osteoporosis
J. Bilezikian (2001)
10.1016/0378-5122(92)90099-P
Treatment of postmenopausal osteoporosis with calcitriol or calcium.
M. Tilyard (1992)
10.1016/0378-5122(91)90212-9
Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women.
C. Gennari (1990)
10.1007/3-540-30683-8_1769
[Vitamin D3].
S. Dyderski (1999)
10.7326/0003-4819-113-9-649
Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study.
J. Gallagher (1990)
10.1210/JCEM.85.11.6938
Relationship of intestinal calcium absorption to 1,25-dihydroxyvitamin D [1,25(OH)2D] levels in young versus elderly women: evidence for age-related intestinal resistance to 1,25(OH)2D action.
S. Pattanaungkul (2000)
10.1016/B978-012470862-4/50069-6
Vitamin D and Its Metabolites in the Management of Osteoporosis
I. Reid (2001)



This paper is referenced by
Vitamin D status and bone mineral density in women of reproductive and postmenopausal age groups: a cross-sectional study from south India.
C. Harinarayan (2011)
10.1371/JOURNAL.PMED.0040103
A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer
H. Li (2007)
10.1016/J.JAMDA.2006.07.005
Vitamin D deficiency in residents of academic long-term care facilities despite having been prescribed vitamin D.
Zulekha Hamid (2007)
10.1210/JC.2004-1765
Body fat and vitamin D status in black versus white women.
A. Looker (2005)
GUIDELINES FOR EVALUATION OF THE NUTRITIONAL STATUS AND GROWTH IN REFUGEE CHILDREN DURING THE DOMESTIC MEDICAL SCREENING EXAMINATION
(2012)
A glimpse from the past: osteoporosis and osteoporotic fractures in a Portuguese identified skeletal sample.
F. Curate (2013)
10.1016/S0151-9638(07)89240-4
Vitamine D et soleil : risques et bénéfices chez l’enfant
Pierre Vabres (2007)
10.1002/jcph.1071
Regulatory Perspectives in Pharmacometric Models of Osteoporosis
Kumpal Madrasi (2018)
10.1016/J.BONE.2004.03.031
Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice.
Debbie Fonseca (2004)
Investigation of the molecular mechanisms of Fructus Ligustri Lucidi on calcium balance and vitamin D metabolism
Sisi Cao (2017)
10.1007/s11154-011-9187-z
Treatment of osteopenia
E. Eriksen (2011)
10.1007/s11914-014-0221-4
Aneuploidy and Skeletal Health
Archana Kamalakar (2014)
Mini Review: Prevalence and correlates of vitamin D deficiency-perspectives from Pakistan.
S. Akhtar (2016)
10.1507/ENDOCRJ.K06-001
Hypovitaminosis D in type 2 diabetes mellitus: Association with microvascular complications and type of treatment.
Atsushi Suzuki (2006)
Efectos de la intervención nutricional con un preparado lácteo enriquecido en ácidos grasos poliinsaturados omega-3, ácido oleico y vitaminas sobre marcadores relacionados con el riesgo cardiovascular y con el metabolismo óseo en pacientes dislipémicos
E. Bautista (2006)
[Calciotropic actions of parathyroid hormone and vitamin D-endocrine system].
Euclides Avila (2007)
10.1177/147323000403200602
The Effects of Calcitriol Therapy on Serum Interleukin-1, Interleukin-6 and Tumour Necrosis Factor-α Concentrations in Post-menopausal Patients with Osteoporosis
A. Inanır (2004)
10.1016/j.ijotn.2019.100709
Predictors of fragility fractures and osteoporosis among people over 50 years old - a retrospective cohort study.
M. Meriläinen (2019)
10.1007/978-3-319-46029-1_6-1
Melanoma Prevention and Screening
S. Swetter (2019)
COMPARISON OF ORAL AND INJECTABLE VITAMIN D ON BONE MINERAL DENSITY IN PERI AND POSTMENOPAUSAL WOMEN WITH HYPOVITAMINOSIS D
N. Kumari (2015)
10.1007/s00774-009-0147-6
Cooperative effect of serum 25-hydroxyvitamin D concentration and a polymorphism of transforming growth factor-β1 gene on the prevalence of vertebral fractures in postmenopausal osteoporosis
S. Mori (2009)
10.1007/s40618-020-01265-x
Monthly fluctuations in 25-hydroxy-vitamin D levels in day and rotating night shift hospital workers
S. Rizza (2020)
10.1016/B978-0-12-415853-5.00013-3
Vitamin D: Biology, Actions, and Clinical Implications
D. Feldman (2001)
10.1016/J.JOT.2016.06.147
Use of the collaborative cross gene mine mouse phenotype library to identify novel genes regulating bone mass and bone architecture
Jinbo Yuan (2016)
10.1359/JBMR.050605
A New Vitamin D Analog, 2MD, Restores Trabecular and Cortical Bone Mass and Strength in Ovariectomized Rats With Established Osteopenia
H. Ke (2005)
10.5694/j.1326-5377.2006.tb00558.x
Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement
C. Munns (2006)
10.1007/s00198-004-1718-y
Clinical utility of laboratory testing in women with osteoporosis
S. Jamal (2004)
10.1359/jbmr.080328
Low Serum 25‐Hydroxyvitamin D Levels Associated With Falls Among Japanese Community‐Dwelling Elderly
T. Suzuki (2008)
10.1016/B978-012370544-0.50015-X
CHAPTER 13 – Vitamin D: Biology, Action, and Clinical Implications
D. Feldman (2008)
Vitamin D , Serum Calcium and Bone Mineral Density in pre and post menopausal women-a pilot study
D. Lavanya (2015)
10.1111/j.1600-0412.2012.01473.x
New developments in the treatment of osteoporosis
E. Eriksen (2013)
10.1074/jbc.M504179200
Unloading Induces Osteoblastic Cell Suppression and Osteoclastic Cell Activation to Lead to Bone Loss via Sympathetic Nervous System*
H. Kondo (2005)
See more
Semantic Scholar Logo Some data provided by SemanticScholar